Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ · Financial Services
Bellevue Life Sciences Acquisition Corp. Shareholder Equity 2021–2023
Bellevue Life Sciences Acquisition Corp. annual shareholder equity history from 2020 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bellevue Life Sciences Acquisition Corp. shareholder equity as of December 31, 2023: 32.5M, a 86800.07% decrease year-over-year.
- Bellevue Life Sciences Acquisition Corp. shareholder equity for 2023 were 32.5M, a 86800.07% decrease from 2022.
- Bellevue Life Sciences Acquisition Corp. shareholder equity for 2022 were -37,508, a 1669.25% increase from 2021.
- Bellevue Life Sciences Acquisition Corp. shareholder equity for 2021 were -2,120, a 278.45% decrease from 2020.
- Bellevue Life Sciences Acquisition Corp. shareholder equity for 2020 were 1,188.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bellevue Life Sciences Acquisition Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $33 |
| 2022 | $-0 |
| 2021 | $-0 |
| 2020 | $0 |
Bellevue Life Sciences Acquisition Corp. Shareholder Equity — FAQ
Bellevue Life Sciences Acquisition Corp. (BLAC) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLAC's shareholder equity history?
The chart and table above show Bellevue Life Sciences Acquisition Corp.'s shareholder equity by year and by quarter, including the growth rate.